Evidence map›Paper›PMID 16622218›Full record

ArticleInfection and immunity2006

Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.

Jannet Katz, Ping Zhang, Michael Martin, Stefanie N Vogel, Suzanne M Michalek

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 121 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Innate Immune Recognition: An Issue More Complex Than Expected.Frontiers in cellular and infection microbiology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Innate Immune Recognition: Implications for the Interaction ofFrontiers in cellular and infection microbiology · 2017
    Review
  13. Efficacy of Resistance toFrontiers in immunology · 2017
    Article
  14. Article
  15. Endotoxemia-menace, marker, or mistake?Journal of leukocyte biology · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jannet KatzDepartment of Pediatric Dentistry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Ping Zhang
Michael Martin
Stefanie N Vogel
Suzanne M Michalek
University of Alabama at Birmingham · USUniversity of Maryland, Baltimore · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CROSS, ALAN S. · 2003 to 2013
$91.5M
Genetically Engineered Oral Vaccines &Caries ImmunityR01DE009081 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1990 to 2012
$3.2M
Mechanisms of Immune Modulation and Periodontal DiseaseR01DE014215 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZ, JANNET · 2001 to 2011
$2.8M
Development of a Mucosal Vaccine Against F. tularensisU01AI056460 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 2003 to 2007
$2.5M
Mechanisms of Immune Modulation and Periodontal DiseaseR56DE014215 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZ, JANNET · 2007 to 2007
$364k
NIAID NIH HHS AI56460NIAID NIH HHS AI57168NIAID NIH HHS U01 AI056460NIAID NIH HHS U54 AI057168NIDCR NIH HHS DE09081NIDCR NIH HHS DE14215NIDCR NIH HHS R01 DE009081NIDCR NIH HHS R01 DE014215NIDCR NIH HHS R56 DE014215
6 · The paper itself

Abstract

Francisella tularensis, a gram-negative bacterium, is the etiologic agent of tularemia and has recently been classified as a category A bioterrorism agent. Infections with F. tularensis result in an inflammatory response that plays an important role in the pathogenesis of the disease; however, the cellular mechanisms mediating this response have not been completely elucidated. In the present study, we determined the role of Toll-like receptors (TLRs) in mediating inflammatory responses to F. tularensis LVS, and the role of NF-kappaB in regulating these responses. Stimulation of bone marrow-derived dendritic cells from C57BL/6 wild-type (wt) and TLR4-/- but not TLR2-/- mice, with live F. tularensis LVS elicited a dose-dependent increase in the production of tumor necrosis factor alpha. F. tularensis LVS also induced in a dose-dependent manner an up-regulation in the expression of the costimulatory molecules CD80 and CD86 and of CD40 and the major histocompatibility complex class II molecules on dendritic cells from wt and TLR4-/- but not TLR2-/- mice. TLR6, not TLR1, was shown to be involved in mediating the inflammatory response to F. tularensis LVS, indicating that the functional heterodimer is TLR2/TLR6. Stimulation of dendritic cells with F. tularensis resulted in the activation of NF-kappaB, which resulted in a differential effect on the production of pro- and anti-inflammatory cytokines. Taken together, our results demonstrate the role of TLR2/TLR6 in the host's inflammatory response to F. tularensis LVS in vitro and the regulatory function of NF-kappaB in modulating the inflammatory response.

Indexed as

AnimalsB7-1 AntigenB7-2 AntigenCD40 AntigensFrancisella tularensisInflammationInterleukin-10MiceMice, Inbred C57BLNF-kappa BToll-Like Receptor 1Toll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 6Tumor Necrosis Factor-alphaB7-1 AntigenB7-2 AntigenCD40 AntigensCd86 protein, mouseInterleukin-10NF-kappa BTlr2 protein, mouseTlr4 protein, mouseTlr6 protein, mouseToll-Like Receptor 1Toll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 6Tumor Necrosis Factor-alpha

Identifiers

PMID16622218
PMCPMC1459727
OpenAlexW1999314991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.